Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
Open Access
- 25 April 2005
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 201 (9), 1479-1486
- https://doi.org/10.1084/jem.20050473
Abstract
Systemic onset juvenile idiopathic arthritis (SoJIA) encompasses ∼10% of cases of arthritis that begin in childhood. The disease is unique in terms of clinical manifestations, severity of joint involvement, and lack of response to tumor necrosis factor blockade. Here, we show that serum from SoJIA patients induces the transcription of innate immunity genes, including interleukin (IL)-1 in healthy peripheral blood mononuclear cells (PBMCs). Upon activation, SoJIA PBMCs release large amounts of IL-1β. We administered recombinant IL-1 receptor antagonist to nine SoJIA patients who were refractory to other therapies. Complete remission was obtained in seven out of nine patients and a partial response was obtained in the other two patients. We conclude that IL-1 is a major mediator of the inflammatory cascade that underlies SoJIA and that this cytokine represents a target for therapy in this disease.Keywords
This publication has 33 references indexed in Scilit:
- The German etanercept registry for treatment of juvenile idiopathic arthritisAnnals Of The Rheumatic Diseases, 2004
- Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateArthritis & Rheumatism, 2004
- Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor α blockadeArthritis & Rheumatism, 2004
- Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinraArthritis & Rheumatism, 2004
- Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typeArthritis & Rheumatism, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 2003
- Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trialArthritis & Rheumatism, 2003
- Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus ErythematosusScience, 2001
- Correlation of Serum Interleukin‐6 Levels with Joint Involvement and Thrombocytosis in Systemic Juvenile Rheumatoid ArthritisArthritis & Rheumatism, 1991
- A study of classification criteria for a diagnosis of juvenile rheumatoid arthritisArthritis & Rheumatism, 1986